Abstract
Smoking and hypertension are recognized as two major cardiovascular risk factors accounting for the greatest proportion of cardiovascular morbidity and mortality. According to the latest estimate by the World Health Organization, more than 12 million deaths are attributable to high blood pressure and smoking. The overall risk of major cardiovascular events increases dramatically as the prevalence of hypertension and tobacco use is projected to rise further. The relationship between smoking and high blood pressure is multifactorial. Several common pathophysiological mechanisms have been proposed for the association between smoking and hypertension-related cardiovascular consequences. Smoking cessation and better blood pressure control should be the main goal of physicians’ intervention to improve cardiovascular outcome.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
WHO (2009) Global health risks: mortality and burden of disease attributable to selected major risks
WHO report on the global tobacco epidemic (2008) World Health Organization, Geneva
The tobacco atlas. The third edition. download: from www.tobaccoatlas.org on 04.01.2012] World Health organization
Costanza MC, Salamun J, Lopez AD, Morabia A (2006) Gender differentials in the evolution of cigarette smoking habits in a general European adult population from 1993–2003. BMC Public Health 6:130
Rahmanian SD, Diaz PT, Wewers ME (2011) Tobacco use and cessation among women: research and treatment-related issues. J Womens Heal (Larchmt) 20:349–357
Huxley RR, Woodward M (2011) Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 378:1297–1305
Oberg M, Jaakkola MS, Woodward A et al (2011) Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet 377:139–146
Jamrozik K (2005) Estimate of deaths attributable to passive smoking among UK adults: database analysis. BMJ 330:812
Kannel WB, Higgins M (1990) Smoking and hypertension as predictors of cardiovascular risk in population studies. J Hypertens Suppl 8:S3–S8
Ezzati M, Henley SJ, Thun MJ, Lopez AD (2005) Role of smoking in global and regional cardiovascular mortality. Circulation 112:489–497
Hallstrom AP, Cobb LA, Ray R (1986) Smoking as a risk factor for recurrence of sudden cardiac arrest. N Engl J Med 314:271–275
Ambrose JA, Barua RS (2004) The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43:1731–1737
Yusuf S, Hawken S, Ounpuu S et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937–952
Colditz GA, Bonita R, Stampfer MJ et al (1988) Cigarette smoking and risk of stroke in middle-aged women. N Engl J Med 318:937–941
Mannami T, Iso H, Baba S et al (2004) Cigarette smoking and risk of stroke and its subtypes among middle-aged Japanese men and women: the JPHC study cohort I. Stroke 35:1248–1253
Navas-Acien A, Selvin E, Sharrett AR et al (2004) Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation 109:3196–3201
Conen D, Everett BM, Kurth T et al (2011) Smoking, smoking cessation, [corrected] and risk for symptomatic peripheral artery disease in women: a cohort study. Ann Intern Med 154:719–726
Willi C, Bodenmann P, Ghali WA et al (2007) Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 298:2654–2664
Fagard RH (2009) Smoking amplifies cardiovascular risk in patients with hypertension and diabetes. Diabetes Care 32:S429–S431
Barnoya J, Glantz SA (2005) Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation 111:2684–2698
Raupach T, Schafer K, Konstantinides S, Andreas S (2006) Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm. Eur Heart J 27:386–392
Glantz FK, Glantz SA (2006) Protecting Europeans from secondhand smoke: time to act. Eur Heart J 27:382–383
Cellina GU, Honour AJ, Littler WA (1975) Direct arterial pressure, heart rate, and electrocardiogram during cigarette smoking in unrestricted patients. Am Heart J 89:18–25
Groppelli A, Giorgi DM, Omboni S et al (1992) Persistent blood pressure increase induced by heavy smoking. J Hypertens 10:495–499
Grassi G, Seravalle G, Calhoun DA et al (1994) Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 90:248–253
Najem B, Houssiere A, Pathak A et al (2006) Acute cardiovascular and sympathetic effects of nicotine replacement therapy. Hypertension 47:1162–1167
Green MS, Jucha E, Luz Y (1986) Blood pressure in smokers and nonsmokers: epidemiologic findings. Am Heart J 111:932–940
Lee DH, Ha MH, Kim JR, Jacobs DR Jr (2001) Effects of smoking cessation on changes in blood pressure and incidence of hypertension: a 4-year follow-up study. Hypertension 37:194–198
Halimi JM, Giraudeau B, Vol S et al (2002) The risk of hypertension in men: direct and indirect effects of chronic smoking. J Hypertens 20:187–193
Bowman TS, Gaziano JM, Buring JE, Sesso HD (2007) A prospective study of cigarette smoking and risk of incident hypertension in women. J Am Coll Cardiol 50:2085–2092
Primatesta P, Falaschetti E, Gupta S et al (2001) Association between smoking and blood pressure: evidence from the health survey for England. Hypertension 37:187–193
Mann SJ, James GD, Wang RS, Pickering TG (1991) Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case-control study. JAMA 265:2226–2228
Narkiewicz K, Maraglino G, Biasion T et al (1995) Interactive effect of cigarettes and coffee on daytime systolic blood pressure in patients with mild essential hypertension. HARVEST study group (Italy). Hypertension ambulatory recording VEnetia STudy. J Hypertens 13:965–970
Collins AJ, Li S, Ma JZ, Herzog C (2001) Cardiovascular disease in end-stage renal disease patients. Am J Kidney Dis 38(Suppl 1):S26–S29
Liebman SE, Lamontagne SP, Huang LS et al (2011) Smoking in dialysis patients: a systematic review and meta-analysis of mortality and cardiovascular morbidity. Am J Kidney Dis 58:257–265
Orth SR, Ritz E (2002) The renal risks of smoking: an update. Curr Opin Nephrol Hypertens 11:483–488 37
Pinto-Sietsma SJ, Mulder J, Janssen WM et al (2000) Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 133:585–591
Haroun MK, Jaar BG, Hoffman SC et al (2003) Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington country, Maryland. J Am Soc Nephrol 14:2934–2941
Foley RN, Herzog CA, Collins AJ (2003) Smoking and cardiovascular outcomes in dialysis patients: the United States renal data system wave 2 study. Kidney Int 63:1462–1467
Combe C, Albert JM, Bragg-Gresham JL et al (2009) The burden of amputation among hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 54:680–692
Failla M, Grappiolo A, Carugo S et al (1997) Effects of cigarette smoking on carotid and radial artery distensibility. J Hypertens 15:1659–1664
Celermajer DS, Sorensen KE, Georgakopoulos D et al (1993) Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88:2149–2155
Mancia G, Groppelli A, Di Rienzo M et al (1997) Smoking impairs baroreflex sensitivity in humans. Am J Physiol 273:H1555–H1560
Niedermaier ON, Smith ML, Beightol LA et al (1993) Influence of cigarette smoking on human autonomic function. Circulation 88:562–571
Narkiewicz K, van de Borne PJ, Hausberg M et al (1998) Cigarette smoking increases sympathetic outflow in humans. Circulation 98:528–534
Bazzano LA, He J, Muntner P et al (2003) Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med 138:891–897
Niskanen L, Laaksonen DE, Nyyssonen K et al (2004) Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension 44:859–865
Barutcu I, Esen AM, Degirmenci B et al (2004) Acute cigarette smoking-induced hemodynamic alterations in the common carotid artery–a transcranial Doppler study. Circ J 68:1127–1131
Kim JW, Park CG, Hong SJ et al (2005) Acute and chronic effects of cigarette smoking on arterial stiffness. Blood Press 14:80–85
Payne JR, Eleftheriou KI, James LE et al (2006) Left ventricular growth response to exercise and cigarette smoking: data from LARGE heart. Heart 92:1784–1788
Hering D, Somers VK, Kara T et al (2006) Sympathetic neural responses to smoking are age dependent. J Hypertens 24:691–695
Prescott E, Hippe M, Schnohr P et al (1998) Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 316:1043–1047
Hering D, Somers VK, Kara T et al (2008) Heightened acute circulatory responses to smoking in women. Blood Press 17:141–146
Prescott E, Osler M, Andersen PK et al (1998) Mortality in women and men in relation to smoking. Int J Epidemiol 27:27–32
Boutouyrie P, Tropeano AI, Asmar R et al (2002) Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 39:10–15
Liang YL, Shiel LM, Teede H et al (2001) Effects of blood pressure, smoking, and their interaction on carotid artery structure and function. Hypertension 37:6–11
Mahmud A, Feely J (2003) Effect of smoking on arterial stiffness and pulse pressure amplification. Hypertension 41:183–187
Hering D, Kucharska W, Kara T et al (2010) Smoking is associated with chronic sympathetic activation in hypertension. Blood Press 19:152–155
Miller LG (1990) Cigarettes and drug therapy: pharmacokinetic and pharmacodynamic considerations. Clin Pharm 9:125–135
Laustiola KE, Lassila R, Kaprio J, Koskenvuo M (1988) Decreased beta-adrenergic receptor density and catecholamine response in male cigarette smokers. A study of monozygotic twin pairs discordant for smoking. Circulation 78:1234–1240
Kotamaki M, Manninen V, Laustiola KE (1993) Enalapril versus atenolol in the treatment of hypertensive smokers. Eur J Clin Pharmacol 44:13–17
Hermida RC, Ayala DE, Calvo C et al (2005) Effects of nebivolol on ambulatory blood pressure in smoker and non-smoker hypertensive patients. Am J Hypertens 18:62A–63A
Reims HM, Oparil S, Kjeldsen SE et al (2004) Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the LIFE study. Blood Press 13:376–384
Mancia G, De Backer G, Dominiczak A et al (2007) 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the european society of hypertension (ESH) and of the European society of cardiology (ESC). J Hypertens 25:1105–1187
Wilson K, Gibson N, Willan A, Cook D (2000) Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med 160:939–944
Chase HP, Garg SK, Marshall G et al (1991) Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. JAMA 265:614–617
Jatoi NA, Jerrard-Dunne P, Feely J, Mahmud A (2007) Impact of smoking and smoking cessation on arterial stiffness and aortic wave reflection in hypertension. Hypertension 49:981–985
Janzon E, Hedblad B, Berglund G, Engstrom G (2004) Changes in blood pressure and body weight following smoking cessation in women. J Intern Med 255:266–272
Johnson HM, Gossett LK, Piper ME et al (2010) Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol 55:1988–1995
Tsevat J, Weinstein MC, Williams LW et al (1991) Expected gains in life expectancy from various coronary heart disease risk factor modifications. Circulation 83:1194–1201
Benowitz NL, Gourlay SG (1997) Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 29:1422–1431
Hubbard R, Lewis S, Smith C et al (2005) Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death. Tob Control 14:416–421
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Hering, D., Narkiewicz, K. (2012). Smoking, Nicotine and Blood Pressure. In: Berbari, A., Mancia, G. (eds) Special Issues in Hypertension. Springer, Milano. https://doi.org/10.1007/978-88-470-2601-8_18
Download citation
DOI: https://doi.org/10.1007/978-88-470-2601-8_18
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2600-1
Online ISBN: 978-88-470-2601-8
eBook Packages: MedicineMedicine (R0)